| Place of Origin: | CHINA |
|---|---|
| Brand Name: | BIOF |
| Certification: | ISO KOSHER HALAL |
| Model Number: | Finasteride pills |
| Minimum Order Quantity: | 50g |
| Price: | Negotiable |
| Packaging Details: | 50g 100g 500g 1kg Aluminum Foil Bag |
| Delivery Time: | Within 3 Working Days |
| Payment Terms: | MoneyGram, Western Union, T/T, D/P, D/A |
| Supply Ability: | 100KG Per Week |
| Appearance: | White Fine Powder | CAS: | 98319-26-7 |
|---|---|---|---|
| Molecular Formula: | C23H36N2O2 | EINECS: | 600-534-3 |
| Assay: | 99%+ | Sample: | Available |
| High Light: | Hair Loss Treatment Finasteride Powder,CAS 98319-26-7,98319-26-7 |
||
Hair Loss Treatment CAS 98319-26-7 Finasteride Powder
| Product Name | Finasteride |
| Cas No.: | 98319-26-7 |
| Appearance | Almost white crystalline powder |
| Identification | Complies |
| Particle size | 100%≤20um 90%≤10um |
| Total impurities | 0.3% |
| Assay(HPLC,based on drying) | 99.3% |
Dutasteride is mainly used for prostate enlargement, male hair loss, seborrheic hair loss and hereditary hair loss (women and children should not take it). Dutasteride was relatively specific 5 α- Reductase inhibitors inhibit type I and type II 5 by forming enzyme complexes α- Reductase isozyme can inhibit the conversion of testosterone to dihydrotestosterone (DHT), and then inhibit the production of androgen dihydrotestosterone, so it can inhibit the growth of prostate in patients with benign prostatic hyperplasia (BPH). 0.5mg per day. After 1 ~ 2 weeks of treatment, the effect of this product on reducing DHT reaches the peak, and the plasma DHT can be reduced by 85% ~ 90%. The DHT of patients with enlarged prostate decreased significantly after taking 5mg every day for 12 weeks.
| Product name | Finasteride Powder | ||
| Batch No. | 20210520 | Quantity | 25kg |
| Mfg. Date | May.,20, 2021 | Expiry date | May,19, 2023 |
| Specification | USP 38 Standard | ||
| Items | Standard | Results | ||||||
| Description | white or almost white crystalline powder | almost white crystalline powder | ||||||
| Identification(IR,HPLC) | complies with the standard | complies | ||||||
| Solubility | Free soluble in chloroform and in alcohol ,very slightly soluble in water. | complies | ||||||
| Melting point | About 257℃ | 257.0～258.0℃ | ||||||
| Specific rotation | -56.0°～-60.0° | -58.6° | ||||||
| Specific optical rotation | +12.0°～+14.0° | +12.5° | ||||||
| Water | max.0.3% | 0.08% | ||||||
| Residue on ignition | max.0.1% | 0.05% | ||||||
| Heavy Metals | max.10ppm | complies | ||||||
| Loose Density (g/cm3) | 0.27～0.37 | 0.27 | ||||||
| Tapped Density (g/cm3) | 0.40～0.56 | 0.43 | ||||||
| Particle size | 100%≤20um 90%≤10um | complies | ||||||
| Polymorph | Polymorph I | complies | ||||||
| Chromatographic purity (HPLC) | ||||||||
| Any individual impurity | max.0.5% | 0.20% | ||||||
| Total impurities | max.1.0% | 0.34% | ||||||
| Assay (HPLC, based on drying) | 98.5%～101.0% | 99.3% | ||||||
| Residual solvents | ||||||||
| Acetone | Max.5000ppm | 33ppm | ||||||
| Chloroform | Max.60ppm | n.d | ||||||
| THF | Max.720ppm | n.d | ||||||
| Dichloromethane | Max.600ppm | n.d | ||||||
| Toluene | Max.890ppm | 17ppm | ||||||
| Methanol | Max3000ppm | 57ppm | ||||||
| Organic Volatile | Meet the ICH requirements | complies | ||||||
| Storage:Preserve in tight containers, and store at controlled room temperature. | ||||||||
| Conclusion: The product complies with the requirements of USP 38. | ||||||||
| Analyst | panyong | Checker | panwang | Approved by | yangmingcheng | |||
Function
Primary classification: drugs for urinary system secondary classification: drugs for benign prostatic hyperplasia
1. Use for treatment of Male alopecia, seborrheic alopecia and hereditary alopecia
2. For the treatment of benign prostatic hyperplasia, enlarged prostate shrink, improve urinary flow and improvement of benign prostatic hyperplasia caused symptoms.
